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Background-—The American Heart Association Mission: Lifeline STEMI (ST-segment–elevation myocardial infarction) Systems
Accelerator program, conducted in 16 regions across the United States to improve key care processes, resulted in more patients
being treated within national guideline goals (time from first medical contact to device: <90 minutes for direct presenters to
hospitals capable of performing percutaneous coronary intervention; <120 minutes for transfers). We examined whether the effort
reduced reperfusion disparities in the proportions of female versus male and black versus white patients.
Methods and Results-—In total, 23 809 patients (29.3% female, 82.3% white, and 10.7% black) presented with acute STEMI between
July 2012 and March 2014. Change in the proportion of patients treated within guideline goals was compared between sex and race
subgroups for patients presenting directly to hospitals capable of performing percutaneous coronary intervention (n=18 267) and
patients requiring transfer (n=5542). The intervention was associated with an increase in the proportion of men treated within
guideline goals that presented directly (58.7–62.1%, P=0.01) or were transferred (43.3–50.7%, P<0.01). An increase was also seen
amongwhite patientswho presented directly (57.7–59.9%, P=0.02) or were transferred (43.9–48.8%,P<0.01). Therewas no change in
the proportion of female or black patients treated within guideline goals, including both those presenting directly and transferred.
Conclusion-—The STEMI Systems Accelerator project was associated with an increase in the proportion of patients meeting
guideline reperfusion targets for male and white patients but not for female or black patients. Efforts to organize systems of STEMI
care should implement additional processes targeting barriers to timely reperfusion among female and black patients. ( J Am Heart
Assoc. 2017;6:e007122. DOI: 10.1161/JAHA.117.007122.)
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T he cornerstone of acute ST-segment–elevation myocar-dial infarction (STEMI) treatment is prompt coronary
artery reperfusion to reduce morbidity and mortality. National
guidelines call for primary percutaneous coronary intervention
(PCI) within 90 minutes of paramedic arrival for patients who
call 9-1-1 and are transferred directly to a hospital offering
PCI (PCI-capable) and within 120 minutes of first medical
contact (FMC) for patients requiring interhospital transfer.1
Nevertheless, up to 50% of patients presenting with STEMI fail
to meet national guideline goals for reperfusion therapy.2–5
Furthermore, disparities in both the use and the timing of
reperfusion therapy may exist in vulnerable patient popula-
tions, including women and minorities, particularly black
patients.6–11 However, little contemporary evidence exists to
describe care gaps among such disparate groups, particularly
on a national level.
The Regional Systems of Care Demonstration Project
American Heart Association Mission: Lifeline STEMI Systems
Accelerator program represented the largest effort in the
United States to organize regional STEMI care. It significantly
increased the proportion of patients treated within guideline
goals and significantly reduced reperfusion times among
hospitals implementing care processes compared with those
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that did not.12,13 Recent efforts to improve STEMI reperfusion
times have identified systemic barriers to care resulting from
a highly fragmented healthcare system as a primary imped-
iment to the delivery of rapid reperfusion.12,14–16 To address
system-related delays, interventions were conducted with the
goal of identifying regional gaps, barriers, and inefficiencies in
STEMI care and to implement proven recommendations and
protocols to improve quality and consistency of care. Key
study interventions included organizing and training regional
leadership, identifying barriers to care unique to each region,
establishing common protocols for the diagnosis and treat-
ment of patients with STEMI presenting to emergency medical
services (EMS) personnel or hospitals lacking PCI facilities,
conducting ongoing measurement of and feedback on
performance in hospitals, and having regular reviews of
performance with representatives of hospitals and EMS
agencies.
Despite the success of these programs, little is known
about the specific impact of rapidly implementing multiple
STEMI regional networks on care disparities, including among
female and black patients. The objective of this study was to
determine the impact of implementing regional systems of
STEMI care on the proportion of patients treated within
reperfusion time guideline goals for female versus male and
black versus white patients and to determine whether the
intervention narrowed disparities between these groups.
Methods
Study Design and Population
This study analyzed data collected over 7 calendar quarters
from July 1, 2012 (2012 quarter 3), through March 31,
2014 (2014 quarter 1), as part of the STEMI Systems
Accelerator project. The design and methods for this study
have been published.17 In brief, the STEMI Systems
Accelerator project was a nationwide effort to organize
and implement STEMI reperfusion therapy in 16 regions
across the United States and included 484 hospitals and
1253 EMS agencies. The enrollment criteria for each region
included the following: (1) 70% of PCI-capable hospitals in
the region were participating in the National Cardiovascular
Data Registry’s ACTION Registry–Get With The Guidelines
(AR-G) program; (2) there was defined organization of
regional leadership; (3) common protocols were established
for the diagnosis and treatment of patients with STEMI
presenting to EMS personnel or hospitals lacking PCI
facilities; (4) there was agreement to enter patients into the
AR-G for 6 consecutive quarters; and (5) regional leadership
participated in a 2-day national training session directed by
study faculty reviewing current evidence, guidelines, and
approaches to regional STEMI care. The following 16 of 21
regions that applied for participation in the project met
enrollment criteria by the baseline data collection quarter
and were included: Atlanta, GA; Columbus, OH; Denver, CO;
Hartford, CT; Houston, TX; Kern County, CA; Louisville, KY;
New York, NY; northern New Jersey; Oklahoma City, OK;
Philadelphia, PA; Pittsburgh, PA; St. Louis, MO; San Antonio,
TX; Tampa, FL; and Wilkes-Barre/Scranton, PA.
Regional interventions were based on Mission: Lifeline
established approaches and drew on specific resources that
effectively augmented regional organization in prior experi-
ence (Data S1).18 Each region established common protocols,
including common criteria for establishing the diagnosis of
STEMI, activating a catheterization laboratory with a single
phone or radio call, treating the patient with simple initial
regimens, and transporting the patient by preidentified
mechanisms. Common protocols were implemented, and
ongoing performance measurement and feedback were
conducted and reflected in quarterly hospital STEMI treatment
reports.
Each region identified a quarter (quarters 3 or 4 of 2012
or quarter 1 of 2013) as the baseline quarter (Q1) from
which to assess subsequent temporal trends in outcomes.
All patients with ongoing ischemic symptoms lasting for
>10 minutes but <12 hours, with ECG-diagnosed ST-seg-
ment elevation, and treated with primary PCI were included.
Patients were included in the direct presenter group if they
presented to a PCI-capable hospital (capable of performing
PCI 24/7) either by EMS transport or self-transport.
Patients were included in the transfer group if they
presented to a hospital without PCI capabilities and were
subsequently transferred to a PCI-capable hospital. Analysis
was performed on the overall population represented by all
16 regions.
Clinical Perspective
What Is New?
• Women and black patients have longer ST-segment–
elevation myocardial infarction (STEMI) treatment times
compared with men and white patients.
• Establishment of regional systems of STEMI care has been
shown to improve overall STEMI treatment times, but its
impact on care disparities by sex and race is less clear.
What Are the Clinical Implications?
• Despite implementing regional systems of STEMI care
across health systems in the United States, disparities in
STEMI care persist among women and black patients.
• This study highlights the need to develop regional care
efforts to implement additional processes to overcome
barriers to care for women and black patients.
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Study Outcome
The primary outcome of this study was the percentage of
patients meeting guideline goals for FMC-to-device time. The
outcome was analyzed by sex and race in each of the 7
quarters.
Statistical Analyses
Analyses were conducted to determine the change in the
percentage of patients (female versus male and black versus
white) meeting guideline goals for 6 quarters (after the
baseline quarter). Descriptive statistics for continuous vari-
ables were presented as medians (25th and 75th percentiles).
The Cochran–Armitage test for trend was used to assess
changes in rates over time. Categorical variables are
presented as frequencies with percentages. Baseline charac-
teristics were compared using the Wilcoxon rank sum test for
continuous variables and the Pearson v2 or Fisher exact test,
as appropriate, for categorical variables. In-hospital mortality
was analyzed using the logistic regression model with
generalized estimating equations to account for clustering
of patients within each hospital. Mixed-effects models were
used to estimate the effect of sex and race on the dependent
variable of FMC-to-device time and the interaction between
sex or race and intervention.
All statistical tests were conducted at the nominal 0.05
significance level. Statistical analyses were performed with
SAS version 9.2 or higher (SAS Institute). The project was
reviewed by the Duke University institutional review board
and classified as exempt.
Results
Patient Characteristics and Presentation
A total of 23 809 patients presented with acute STEMI from
July 2012 through March 2014. The population was 70.7%
male, 29.3% female, 82.3% white, and 10.7% black. Overall,
77% of patients were in the direct presenter group and 23%
were in the transfer group. Of the 23 809 patients, 20 797
were treated by primary PCI within 12 hours of symptom
onset and were included in the primary outcome analysis.
Patient demographics, medical history, presenting clinical
characteristics, and in-hospital complications are shown in
Tables 1 and 2.
Women were significantly older and had significantly more
comorbidities, including hypertension, chronic lung disease,
diabetes mellitus, and prior heart failure, compared with men.
Women were also more likely to have Medicare or Medicaid
insurance. Women had a longer delay between symptom
onset and FMC and were more likely to arrive by EMS
transport rather than self-transport. Women who were
transferred had a significantly longer door-in to door-out time
compared with men. Women also had significantly more in-
hospital complications, including in-hospital death, congestive
heart failure, and major bleeding.
Black patients had significantly higher rates of diabetes
mellitus and hypertension and were more likely to be
uninsured compared with white patients. Among those
transferred, black patients had significantly longer door-in to
door-out times. Among direct presenters, black patients had
higher rates of in-hospital complications including cardiogenic
shock and congestive heart failure, whereas complication
rates were similar for black and white patients in the transfer
group. In-hospital mortality was similar for black and white
patients.
Direct Presenter Group
In each quarter, a higher proportion of men were treated
within guideline goals compared with women. The proportion
of women presenting directly to a PCI-capable hospital that
met guideline goals for FMC-to-device time (<90 minutes) did
not change (53.5% in Q1 to 54.2% in Q7, P=0.26). However,
the proportion of directly presenting men treated within
guideline goals increased significantly from 58.7% in Q1 to
62.1% in Q7 (P=0.01) (Figure 1). The sex and intervention
interaction terms were not significant.
In each quarter, a higher proportion of white patients were
treated within guideline goals compared with black patients.
The proportion of black patients in the direct presenter group
meeting guideline goals did not change (54.0% in Q1 to 56.0%
in Q7, P=0.43). However, the proportion of white patients in
the direct presenter group meeting guideline goals increased
modestly but significantly from 57.7% in Q1 to 59.9% in Q7
(P=0.02) (Figure 2). The race and intervention interaction
terms were not significant.
Transfer Group
Among transfers in all regions over 7 calendar quarters, the
proportion of women who were transferred to a PCI-capable
hospital meeting guideline goals for FMC-to-device time
(<120 minutes) did not change over the course of the
intervention (42.8% in Q1 to 36.5% in Q7, P=0.53). The
proportion of transferred male patients meeting guideline
goals significantly increased from 43.3% in Q1 to 50.7% in Q7
(P<0.01) (Figure 1). The sex and intervention interaction
terms were not significant.
The proportion of black patients in the transfer group
treated within guideline goals decreased, although this was
not statistically significant (42.9% in Q1 to 32.3% in Q7,
P=0.54). The proportion of white patients in the transfer
group meeting guideline goals significantly increased from
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Table 1. Patient Characteristics by Sex
Direct Presenter Transfers
Male Female P Value Male Female P Value
Demographics n=12 813 n=5454 n=4021 n=1521
Age, y <0.001 <0.001
Median 59 66 58 64
Q1–Q3 51–67 56–78 51–66 54–75
Race, n (%) 0.114 0.651
White 10 485 (81.8) 4500 (82.5) 3349 (83.3) 1266 (83.2)
Black 1428 (11.1) 617 (11.3) 362 (9.0) 146 (9.6)
Other 900 (7.0) 337 (6.2) 310 (7.7) 109 (7.2)
Insurance, n (%)
Private/HMO 7194 (56.1) 2806 (51.4) <0.001 2254 (56.1) 855 (56.2) 0.013
Medicare 3860 (30.1) 2593 (47.5) <0.001 1223 (30.4) 690 (45.4) <0.001
Medicaid 1030 (8.0) 729 (13.4) <0.001 339 (8.4) 197 (13.0) <0.001
None 2328 (18.2) 650 (11.9) <0.001 703 (17.5) 188 (12.4) <0.001
Other 2362 (18.4) 1358 (24.9) <0.001 755 (18.8) 303 (19.9) 0.333
Medical history, n (%)
Hypertension 8139 (63.5) 3924 (71.9) <0.001 2507 (62.3) 1047 (68.8) <0.001
Current/recent smoker 5262 (41.1) 1998 (36.6) <0.001 1794 (44.6) 656 (43.1) 0.330
Dyslipidemia 4483 (35.0) 1973 (36.2) 0.114 1334 (33.2) 497 (32.7) 0.200
Chronic lung disease 605 (4.7) 470 (8.6) <0.001 234 (5.8) 127 (8.3) <0.001
Diabetes mellitus 3170 (24.7) 1746 (32.0) <0.001 921 (22.9) 491 (32.3) <0.001
Prior MI 1661 (13.0) 574 (10.5) <0.001 438 (10.9) 142 (9.3) 0.303
Prior heart failure 370 (2.9) 261 (4.8) <0.001 103 (2.6) 54 (3.6) 0.017
Prior PCI 1833 (14.3) 612 (11.2) <0.001 475 (11.8) 143 (9.4) 0.057
Prior CABG 515 (4.0) 170 (3.1) 0.003 175 (4.4) 35 (2.3) 0.001
Presentation
Arrival mode
EMS transport 8002 (62.5) 3763 (69.0) <0.001 NA NA
Self-transport 4811 (37.5) 1691 (31.0) <0.001 NA NA
Door-in to door-out time, min <0.0001
Median NA NA 60 65
Q1–Q3 NA NA 41–97 45–112
Symptom onset to FMC, min <0.001 <0.001
Median 60 70 86 100
Q1–Q3 29.0–152.0 30.0–184.0 45.0–188.0 50.5–250.0
ED time (min), n (%) <0.001 0.694
≤20 2385 (18.6) 779 (14.3) 410 (10.2) 160 (10.5)
>20 to ≤30 2073 (16.2) 766 (14.0) 184 (4.6) 72 (4.7)
>30 to ≤45 2904 (22.7) 1145 (21.0) 614 (15.3) 236 (15.5)
>45 4376 (34.2) 2012 (36.9) 536 (13.3) 184 (12.1)
Shock, n (%) 1026 (8.0) 502 (9.2) 0.008 307 (7.6) 158 (10.4) <0.001
Heart failure, n (%) 776 (6.1) 481 (8.8) <0.001 278 (6.9) 139 (9.1) 0.005
Continued
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43.9% in Q1 to 48.8% in Q7 (P<0.01) (Figure 2). In each
quarter, a higher proportion of white patients were reperfused
within guideline goals compared with black patients. The race
and intervention interactions term were not significant.
Discussion
Establishment of regional systems of STEMI care has been
shown to improve STEMI treatment times and is a class I
recommendation in the American College of Cardiology
Foundation and American Heart Association STEMI manage-
ment guidelines.1,19 In this study, implementing systems of
STEMI care across multiple regions was associated with a
significant increase in the proportion of male and white
patients meeting guideline goals for FMC-to-device times
among both direct presenters and transfers that was not
evident for female or black patients, highlighting important
contemporary care gaps that remain in the United States
despite regional efforts.
Disparities in the management of STEMI by sex have been
documented previously.6–9,11 A study of 2.5 million patients
in the National Registry of Myocardial Infarction database
demonstrated that women were significantly less likely to
receive reperfusion therapy compared with men.11 Although
the use of primary PCI for STEMI remained imbalanced in the
current study, differences between men and women have
significantly narrowed, particularly following intervention (Q1:
91.1% in men versus 84% in women, P<0.01; Q6 and Q7:
91.5% in men versus 87.1% in women, P<0.01). Furthermore,
prior studies have shown that women who do receive
reperfusion therapy have longer overall ischemic times and
door-to-balloon times compared with men.6,7,9 This study
extends these prior findings by consistently demonstrating
that a higher proportion of men were reperfused within
guideline goals compared with women despite a national
effort to organize STEMI care across multiple STEMI networks.
Despite the success of programs organizing regional
systems of STEMI care, the impact of these programs on
disparities in reperfusion therapy by sex is not well character-
ized. To our knowledge, the only other study to examine this is
the RACE (Reperfusion of Acute Myocardial Infarction in North
Carolina Emergency Departments) study, a statewide systems
of STEMI care project conducted in North Carolina, which
demonstrated thatwomenhad significant improvement in door-
to-device times although not to a greater extent than men.6 The
considerably larger and heterogeneous population of the STEMI
Systems Accelerator project, which was implemented across
multiple systems of care in the United States, allowed for more
widespread characterization of the impact of organizing STEMI
care in vulnerable patient populations. In contrast to the results
of the RACE study, the intervention in this study benefited men
but not women. The difference in findings may be explained by
the use of the more contemporary FMC-to-device time (incor-
porating prehospital system delays) rather than door-to-device
time or by heterogeneity in both patient population and regional
differences over time.
Similar to women, black patients are also less likely to
receive reperfusion therapy compared with white patients,
Table 1. Continued
Direct Presenter Transfers
Male Female P Value Male Female P Value
Reperfusion candidate, n (%) 12 330 (96.2) 5098 (93.5) <0.001 3811 (94.8) 1423 (93.6) 0.075
Heart rate 0.002 0.002
Median 79 80 78 80
Q1–Q3 66–93 66–96 65–93 68–96
Systolic BP, mm Hg <0.001 0.087
Median 140 138 143 142
Q1–Q3 119–161 114–160 122–163 120–161
Complications, n (%)
In-hospital death 671 (5.2) 465 (8.5) <0.001 188 (4.7) 118 (7.8) <0.001
Stroke 78 (0.6) 57 (1.0) 0.002 35 (0.9) 16 (1.1) 0.530
Cardiogenic shock 948 (7.4) 502 (9.2) 0.625 282 (7.0) 139 (9.1) 0.008
Congestive heart failure 714 (5.6) 429 (7.9) <0.001 232 (5.8) 113 (7.4) 0.023
Major bleeding 451 (3.5) 336 (6.2) <0.001 133 (3.3) 100 (6.6) <0.001
BP indicates blood pressure; CABG, coronary artery bypass grafting; ED, emergency department; EMS, emergency medical services; FMC, first medical contact; HMO, health maintenance
organization; MI, myocardial infarction; NA, not assessed; PCI, percutaneous coronary intervention; Q, quarter.
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Table 2. Patient Characteristics by Race
Direct Presenter Transfers
White Black P Value White Black P Value
Demographics n=14 985 n=2045 n=4615 n=508
Age, y <0.001 0.776
Median 61 60 60 60
Q1–Q3 53–71 52–70 52–69 51–69
Sex, n (%) 0.896 0.531
Male 10 485 (70.0) 1428 (69.8) 3349 (72.6) 362 (71.3)
Female 4500 (30.0) 617 (30.2) 1266 (27.4) 146 (28.7)
Insurance, n (%)
Private/HMO 8434 (56.3) 968 (47.3) <0.001 2625 (56.9) 258 (50.8) 0.591
Medicare 5337 (35.6) 718 (35.1) <0.001 1609 (34.9) 171 (33.7) <0.001
Medicaid 1414 (9.4) 224 (11.0) <0.001 448 (9.7) 45 (8.9) 0.740
None 2307 (15.4) 414 (20.2) <0.001 728 (15.8) 98 (19.3) 0.041
Other 2970 (19.8) 477 (23.3) <0.001 857 (18.6) 112 (22.0) 0.058
Medical history, n (%)
Hypertension 9766 (65.2) 1452 (71.0) <0.001 2907 (63.0) 347 (68.3) 0.019
Current/recent smoker 5997 (40.0) 826 (40.4) 0.750 2046 (44.3) 201 (39.6) 0.040
Dyslipidemia 5211 (34.8) 721 (35.3) 0.024 1540 (33.4) 154 (30.3) 0.005
Chronic lung disease 916 (6.1) 96 (4.7) 0.035 323 (7.0) 17 (3.3) 0.043
Diabetes mellitus 3913 (26.1) 653 (31.9) <0.001 1137 (24.6) 150 (29.5) 0.017
Prior MI 1800 (12.0) 261 (12.8) 0.069 494 (10.7) 40 (7.9) 0.777
Prior heart failure 488 (3.3) 85 (4.2) 0.010 131 (2.8) 11 (2.2) 0.983
Prior PCI 1991 (13.3) 265 (13.0) 0.687 523 (11.3) 47 (9.3) 0.656
Prior CABG 580 (3.9) 52 (2.5) 0.008 182 (3.9) 16 (3.1) 0.878
Presentation
Arrival mode
EMS transport 9510 (63.3) 1456 (71.2) <0.001 NA NA
Self-transport 5475 (36.7) 589 (28.8) 0.869 NA NA
Door-in–door-out time, min <0.001
Median NA NA 60 73
Q1–Q3 NA NA 41–97 43–129
Symptom onset–FMC, min 0.983 0.036
Median 63 61 88 106
Q1–Q3 30.0–161.0 30.0–170.0 47.0–196.0 51.0–254.0
ED time (min), n (%) 0.353 <0.001
≤20 2594 (17.3) 323 (15.8) 391 (8.5) 62 (12.2)
>20–≤30 2307 (15.4) 323 (15.8) 186 (4.0) 70 (13.8)
>30–≤45 3362 (22.4) 430 (21.0) 584 (12.7) 116 (22.8)
>45 5268 (35.2) 724 (35.4) 553 (12.0) 134 (26.4)
Shock, n (%) 1228 (8.2) 190 (9.3) 0.094 391 (8.5) 51 (10.0) 0.237
Heart failure, n (%) 948 (6.3) 163 (8.0) 0.005 345 (7.5) 37 (7.3) 0.878
Reperfusion candidate, n (%) 14 321 (95.6) 1913 (93.5) 0.006 4363 (94.5) 467 (91.9) 0.019
Continued
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and those who are treated by primary PCI have longer
reperfusion times.10,11,20,21 Differences between black and
white patients in the use of primary PCI in this study was
redemonstrated in the preintervention group (89.3% in white
versus 84.9% in black patients in Q1, P=0.01) but were no
longer present following intervention (90.6% in white versus
88.2% in black patients in Q6 and Q7, P=0.14). Consistent
with prior findings, this study also showed that black patients
had longer reperfusion times compared with white
patients.10,21
Although implementing regional systems of STEMI care
improves reperfusion times and the proportion of patients
reperfused within guideline goals, this study demonstrates
that sex and race disparities in STEMI care persist despite
intervention. Consequently, the intervention did not eliminate
barriers to care among female and black patients. This study
highlights future opportunities to further improve the impact
of implementing regional systems of STEMI care by incorpo-
rating additional care processes that address treatment
barriers unique to female and black patients. Reasons for
sex- and race-related disparities in STEMI care have been
described previously.
Women have been shown to have longer reperfusion times
compared with men for numerous reasons, including atypical
symptoms and lack of chest discomfort, ECG with lower
magnitude of ST-segment elevation, greater likelihood of a
missed prehospital diagnosis of STEMI, longer delay between
ECG acquisition and activation of the catheterization team,
higher incidence of presentation to a non-PCI hospital, and
higher risk of interhospital transfer resulting in delay of
transfer.8,9,22–26 Delay in seeking medical care is also more
frequent among women for several reasons, including less
knowledge about symptoms of STEMI, advanced age, greater
likelihood to contact their physician initially, and greater
likelihood of living alone or being widowed.27 In this study, it
is plausible that symptom presentation among women
contributed to a longer delay in obtaining an ECG and
confounded the diagnosis, which may be reflected in longer
emergency department dwell times. In addition, a longer delay
between symptom onset and FMC as well as older age and
more comorbidities may explain the sicker initial presentation
of women, with higher rates of cardiogenic shock and heart
failure on presentation. Finally, women had significantly
longer door-in to door-out times. The current intervention
did not include education to specifically address atypical
presentation in certain populations, including women and
older adults. Additional education, particularly of EMS agen-
cies, on the presentation in women and training to obtain an
ECG even for atypical symptoms can allow for earlier
diagnosis. In addition, providers should be educated to
activate the catheterization team for a diagnostic ECG despite
atypical symptoms. Finally, further analysis to understand why
women have longer transfer times is necessary.
Race-related disparities have been attributed predomi-
nantly to differences in the care delivered at hospitals that
treat a higher proportion of minorities as well as income and
type of insurance.10,21,28 In this study, black patients were
more likely to be uninsured, and this may have contributed to
differential care compared with white patients. Future
endeavors should compare outcomes of hospitals that treat
a higher proportion of black patients with other hospitals
within the region to examine whether there are differences in
Table 2. Continued
Direct Presenter Transfers
White Black P Value White Black P Value
Heart rate 0.002 0.027
Median 80 80 79 80
Q1–Q3 66–94 67–96 65–93 68–95
Systolic BP, mm Hg 0.990 0.749
Median 140 140 143 140
Q1–Q3 118–161 118–160 122–163 121–164
Complications, n (%)
In-hospital death 905 (6.0) 138 (6.7) 0.210 247 (5.4) 32 (6.3) 0.372
Stroke 102 (0.7) 23 (1.1) 0.028 41 (0.9) 5 (1.0) 0.803
Cardiogenic shock 1152 (7.7) 186 (9.1) 0.027 330 (7.2) 47 (9.3) 0.086
Congestive heart failure 901 (6.0) 152 (7.4) 0.013 267 (5.8) 32 (6.3) 0.644
Major bleeding 632 (4.2) 103 (5.0) 0.088 194 (4.2) 15 (3.0) 0.175
BP indicates blood pressure; CABG, coronary artery bypass grafting; ED, emergency department; EMS, emergency medical services; FMC, first medical contact; HMO, health maintenance
organization; MI, myocardial infarction; NA, not assessed; PCI, percutaneous coronary intervention; Q, quarter.
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Figure 1. Percentage of patients meeting guideline goals for FMC-to-device time by quarter and sex. Patients
arrived directly at hospitals capable of performing percutaneous coronary intervention (A) or were transferred
(B). FMC indicates first medical contact.
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Figure 2. Percentage of patients meeting guideline goals for FMC-to-device time by quarter and race. Patients
arrived directly at hospitals capable of performing percutaneous coronary intervention (A) or were transferred (B).
FMC indicates first medical contact.
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care. Although common protocols should mitigate differences
in care regardless of race, hospitals treating more black
patients may face additional barriers that hinder the ability to
execute these protocols. Hospitals vary substantially not only
in overall door-to-balloon times but also in key hospital-level
subintervals, including door-to-ECG, ECG-to-lab, and lab-to-
balloon times.29 Comparing these subintervals among hospi-
tals treating minorities may help to more precisely identify
areas in need of improvement. Furthermore, EMS agencies
are funded on a local basis, and those servicing lower
socioeconomic and underserved areas lack adequate
resources, personnel, or training to successfully implement
desired interventions, thus leading to delays in care.30
Ensuring adequate funding will be important to establish
uniform application. In addition, this study showed that the
greatest disparity in reperfusion times was among black
patients in the transfer group: Only 32.3% of black patients
met guideline goals compared with 48.8% of white patients.
Furthermore, the door-in to door-out time was 13 minutes
longer for black patients (P<0.001). This identifies race-
related differences in interhospital transfers as a key area in
need of further research and improvement. Finally, quarterly
performance reports provided to each hospital could include
outcomes by sex and race to provide feedback on the impact
of implementing sex- and race-specific care processes.
To our knowledge, this is the only multiregion study to
determine the impact of implementing regional systems of
STEMI care on female and black patients. Although effectu-
ating care processes improves reperfusion times of an overall
population, this study demonstrates a differential impact of
the intervention based on sex and race. The current study
showed a significant increase in the proportion of male and
white patients treated within guideline goals that was not
evident for female or black patients. This highlights the
persistent disparity in STEMI care among female and black
patients and the importance of ongoing regional care efforts
to implement additional processes to target and eliminate
barriers to care delaying reperfusion times in female and
black patients.
Limitations
This study has some limitations. Because of the observational
nature of measurements, the relationships between the
implementation of the STEMI Systems Accelerator project
and treatment times and outcomes are subject to confound-
ing, including cointervention. Quality-improvement efforts by
participating hospitals and EMS agencies may have con-
tributed to the outcomes. In addition, the willingness of
enrolled hospitals to participate in the AR-G program may
indicate a greater focus on quality improvements and thus
may limit reproducibility at other hospitals.
Conclusion
A national STEMI regionalization program was associated with
an increase in the proportions of male and white patients who
are reperfused within guideline goals for FMC-to-device time
that was not evident for female or black patients. These
results highlight future opportunities to further narrow
treatment differences among disparate populations.
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Supplemental Material
 Data S1.
Study Interventions 
1. Bring together leading regional health care providers and institutions in a collaborative
fashion.
2. Identify and establish regional leadership in emergency cardiac care that includes key
physicians and administrators in emergency medicine and cardiology.
3. Appoint 2 national faculty members per region to serve as advisors and neutral brokers of
competition in partnership with the local AHA staff. Faculty members bring expertise in
regional STEMI system organization, implementation of regional process changes, and
utilization of outcomes data to drive improved system performance.
4. Establish regional commitment to STEMI care improvement from all stakeholders: EMS
providers, ED physicians, EMS administrators, non-PCI hospital and PCI hospital
administrators, state and local government agencies, and professional organizations.
5. Conduct a comprehensive regional evaluation of current STEMI care, including a
geographical map of the region with PCI and non-PCI hospitals.
6. Hold regional leader and national faculty pre-intervention conference calls to recruit and
plan regional education meeting.
7. Conduct and facilitate a regional meeting to launch the effort with both national faculty
and regional leaders to harness representation from all entities and multidisciplinary
teams caring for the STEMI patient (EMS, non-PCI hospital, PCI hospital,
administration, physicians, nurses, paramedics, quality-improvement officials).
8. Develop consensus-based standardized protocols for EMS and transfer-in patients in
accordance with national professional guidelines to address local needs.
9. Discuss specific local STEMI case examples that follow patients from first medical 
contact to device activation in the PCI hospital.  
10. Review quarterly regional STEMI care data with feedback from the NCDR and regional 
AHA Mission: Lifeline teams.  
